Thor Medical ASA has today published its Annual Report for 2023, including the
ESG Report and Corporate Governance Report, as well as the Remuneration Report
for 2023.

The annual financial statements are also published in European Single Electronic
Format (ESEF).  

The reports are attached and also available on Thor Medical's webpage
www.thormedical.no.  

The Annual Accounts were approved by the Board of Directors on 20 March 2023. 


DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.no 

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visit www.thormedical.no